Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 6 of 6
Full-Text Articles in Pathology
Cauda Equina Neuroendocrine Tumor (Paraganglioma), Cameron Summers-Powell, Tricia O'Brien, Susana Ferra
Cauda Equina Neuroendocrine Tumor (Paraganglioma), Cameron Summers-Powell, Tricia O'Brien, Susana Ferra
East Florida Research Day 2023
No abstract available.
Fumarate-Hydratase Deficient Leiomyoma – An Opportunity To Intervene, Gul Wymer, Brittany Nagel, Susana Ferra
Fumarate-Hydratase Deficient Leiomyoma – An Opportunity To Intervene, Gul Wymer, Brittany Nagel, Susana Ferra
East Florida Research Day 2023
No abstract available.
Microscopic Extraovarian Sex Cord Proliferations, Tricia O'Brien, Cameron Summers-Powell, Susana Ferra
Microscopic Extraovarian Sex Cord Proliferations, Tricia O'Brien, Cameron Summers-Powell, Susana Ferra
East Florida Research Day 2023
No abstract available.
Unsuspected Large B-Cell Lymphoma Diagnosed By Pleural Effusion Cytology After Chest Wall Trauma, Matthew Lee, Susana Ferra
Unsuspected Large B-Cell Lymphoma Diagnosed By Pleural Effusion Cytology After Chest Wall Trauma, Matthew Lee, Susana Ferra
East Florida Research Day 2023
No abstract available.
Comparing The Expression Of Er, Pr, Her-2 Between Initial Biopsy And Excision Specimens In Invasive Breast Carcinoma Cases. Is There A Need For Universal Repeat Testing?, Gul Wymer, Astrid Sacasa, Susana Ferra
Comparing The Expression Of Er, Pr, Her-2 Between Initial Biopsy And Excision Specimens In Invasive Breast Carcinoma Cases. Is There A Need For Universal Repeat Testing?, Gul Wymer, Astrid Sacasa, Susana Ferra
East Florida Research Day 2023
BACKGROUND: The current College of American Pathologist (CAP) recommendation is that breast biomarkers Estrogen (ER), Progesterone (PR) and HER2 neu (Her2) testing be done on all primary invasive breast carcinomas and on recurrent or metastatic tumors with the aim to identify patients that will benefit from hormonal treatment or anti-Her2 therapy. Repeat testing on a subsequent specimen is not usually indicated unless results appear discordant with the histopathologic findings. The objective of the current study was to evaluate the need of adopting universal reflex re-testing of breast biomarkers in subsequent excision specimens. The rationale behind this study was based upon …
Extra-Axial Desmoplastic/Nodular Medulloblastoma, Shh-Activated In Adult: A Case Report, Gul Wymer, Fatemeh Mousavi, Jennifer Barker
Extra-Axial Desmoplastic/Nodular Medulloblastoma, Shh-Activated In Adult: A Case Report, Gul Wymer, Fatemeh Mousavi, Jennifer Barker
East Florida Research Day 2023
Introduction: Medulloblastoma (MB) is an embryonal central nervous system (CNS) tumor located in the posterior cranial fossa. Medulloblastoma is one of the most common malignant pediatric brain tumors, accounts for 25% of all pediatric intracranial tumors, but rare in adults; and constitute 0.4%-1% of adult primary brain tumors. The incidence of medulloblastomas in adults is approximately 0.5 per million per year and decreases with age with male predominance. Medulloblastomas classically appear as well-defined masses in the cerebellum that enhance both computed tomography (CT) of the head and brain magnetic resonance imaging (MRI) with gadolinium contrast. The clinical symptoms and signs …